Skip to main content
. 2021 Mar 19;21:291. doi: 10.1186/s12885-021-08013-1

Fig. 4.

Fig. 4

Adjusted Kaplan–Meier progression-free survival estimates. a Overall NAVIGATOR population vs Study 1002. b NAVIGATOR 300/400 mg subgroup vs Study 1002. c Adjusted PFS landmark analyses for NAVIGATOR population and Study 1002. d Adjusted PFS analyses for NAVIGATOR 300/400 mg subgroup and Study 1002